My Treatment Approach: Advancing Treatment Strategies for HER2+ Metastatic Breast Cancer - Episode 7
HER2CLIMB-02 Trial: Exploring Tucatinib and T-DM1 for HER2+ mBC
Panelists discuss recent data from the HER2CLIMB-02 trial, highlighting the findings and their implications for treatment practices in HER2-positive breast cancer, particularly for patients with brain metastases.
Video Player is loading.
Video content above is prompted by the following:
- What insights have recent data from HER2CLIMB-02 demonstrated, and what implications may these findings have on treatment practices? (Hurvitz S et al, SABCS 2023. Abstract GS01-10)
Related Content:
